MEDICAGO UNLEASH THE POWER OF PLANTS
associated with 11 other trademarks
Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of ph...

Words that describe this trademark:

therapeutic proteins  human vaccines  antibodies treatment  medicinal preparations  proteins antibodies  treatment  substances  pharmaceutical  vaccines  preparations 

Serial Number:

90620821

Mark:

MEDICAGO UNLEASH THE POWER OF PLANTS

Status:

Registered

Status Date:

10-11-2022

Filing Date:

Registration Number:

6868840

Registration Date:

10-11-2022

Goods and Services:

Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates; Medical information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies

Mark Description:

N/A

Class:

Medical services

Type of Mark:

Trademark

Published for Opposition Date:

07-26-2022

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

CANTOR COLBURN LLP

Correspondent Name:

Recent Trademark filings by this company